Vivos Therapeutics Highlights Silent Threat of Sleep Apnea

Understanding the Unseen Threat of Obstructive Sleep Apnea
Night sweats, teeth grinding, and erectile dysfunction may seem trivial, but these could indicate Obstructive Sleep Apnea (OSA), a pressing health concern impacting over a billion individuals globally. Vivos Therapeutics leads the charge in addressing this issue, aiding healthcare professionals in recognizing these often-overlooked symptoms and providing groundbreaking, non-invasive treatments.
Recognizing OSA: Symptoms and Risks
Millions endure the effects of Obstructive Sleep Apnea without diagnosis. Disruptive indicators such as night sweats and elevated blood pressure are frequently disregarded. These manifesting issues aren't coincidences; they signify the body’s urgent need for attention. According to Kirk Huntsman, Chairman and CEO of Vivos Therapeutics, "Connecting the dots could change your life."
Breaking Down OSA Symptoms
The symptoms of OSA can be misattributed or completely overlooked, leading to years of suffering. Here are some alarming signs that may be linked to OSA:
- Hypertension: Approximately 80% of individuals with resistant hypertension—blood pressure that remains high despite treatment—are likely undiagnosed with OSA. Untreated OSA can worsen heart health significantly over time.
- Erectile Dysfunction (ED): Studies suggest that OSA may affect around 80% of men with ED; the interrupted airflow can hinder healthy blood flow, escalating inflammation and resulting in a detrimental impact on sexual health.
- Heartburn & Acid Reflux: Nighttime acid reflux affects 78% of OSA patients. This condition is due to airway obstructions during sleep, which can draw stomach acid into the esophagus.
- Night Sweats: A third of OSA sufferers experience night sweats stemming from the body's fight-or-flight reaction to falls in oxygen during sleep.
- Teeth Grinding (Bruxism): Sleep bruxism occurs in about 50% of adults with OSA, manifesting as a response to reopen collapsed air passages.
These manifestations pose a substantial missed opportunity for early intervention, according to Huntsman: "This misdiagnosis is a growing public health challenge we are determined to overcome." Understanding these signs can lead to timely and effective diagnosis.
The Vivos Method: A New Approach to Sleep Health
The complexity of OSA often leads to misinterpretations of its symptoms. Vivos Therapeutics is striving to change this narrative. The company emphasizes the importance of acknowledging the body’s signals, which reveal the ramifications of untreated OSA.
Tailored Solutions for OSA
Vivos is revolutionizing OSA care by providing healthcare professionals with the knowledge to spot these signs proactively. Their Centers for Sleep and Airway Medicine offer the latest tools to accurately identify symptoms linked to OSA, ensuring patients receive timely and effective solutions. The Vivos Method utilizes proprietary, FDA-cleared oral appliance technology that naturally reshapes the airway to address and treat OSA, often in less than a year.
This comprehensive model not only addresses symptoms but prevents extensive misdiagnosis and health deterioration. With access to sleep testing, telehealth consultations, and targeted therapies, Vivos aims to facilitate patient recovery long before traditional methodologies do.
"Understanding the real issue behind these symptoms is transformative—it's all about offering personalized care," notes Huntsman. This philosophy underscores Vivos' commitment to enhancing the quality of life for those affected by OSA.
About Vivos Therapeutics
Obstructive Sleep Apnea affects a significant portion of the population, yet most remain undiagnosed and unaware. More than just a sleep disorder, OSA is associated with various chronic health conditions. Vivos Therapeutics, established in 2016, is dedicated to addressing these challenges through innovative technology and collaborative efforts with healthcare providers. With an FDA-cleared device dedicated to treating severe OSA, Vivos aims to change the narrative surrounding sleep health.
The Vivos Method presents a clinically effective, non-surgical, and innovative approach to OSA. Vivos: Breathe New Life. For further information, visit www.vivos.com.
Frequently Asked Questions
What is Obstructive Sleep Apnea (OSA)?
OSA is a serious sleep condition where breathing repeatedly stops and starts during sleep, often leading to various health complications.
What symptoms should I look for regarding OSA?
Common symptoms include loud snoring, night sweats, teeth grinding, high blood pressure, and erectile dysfunction.
How does Vivos Therapeutics help with OSA?
Vivos Therapeutics provides innovative, FDA-cleared treatments that focus on non-surgical airway remodeling to address OSA effectively.
Why is early diagnosis important for OSA?
Early diagnosis can prevent serious health consequences associated with untreated OSA, like hypertension, heart disease, and decreased quality of life.
Can OSA be treated without surgery?
Yes, Vivos offers non-surgical treatment options that effectively manage OSA symptoms through their proprietary methods.
About The Author
Contact Evelyn Baker privately here. Or send an email with ATTN: Evelyn Baker as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.